Page Allyson D, Yorkston Kathryn M
School of Communication Sciences and Disorders, Western University, London, ON N6G 1H1, Canada.
Department of Rehabilitative Medicine, University of Washington, Seattle, WA 98105-6246, USA.
Brain Sci. 2022 Mar 22;12(4):420. doi: 10.3390/brainsci12040420.
Communicative participation is restricted in many conditions associated with dysarthria. This position paper defines and describes the construct of communicative participation. In it, the emergence of this construct is reviewed, along with the predictors of and variables associated with communicative participation in the dysarthrias. In doing so, the features that make communicative participation unique and distinct from other measures of dysarthria are highlighted, through emphasizing how communicative participation cannot be predicted solely from other components of the World Health Organization's International Classification of Functioning, Disability and Health (ICF), including levels of impairment or activity limitations. Next, the empirical literature related to the measurement of communicative participation and how this research relates to dysarthria management is presented. Finally, the development of robust clinical measures of communicative participation and approaches to management is described from the point of view of the clinician. We argue that communicative participation should be a primary focus of treatment planning and intervention to provide patient-centered, holistic, and value-based clinical interventions which are responsive to the needs of individuals living with dysarthria.
在许多与构音障碍相关的情况下，交流参与都会受到限制。本立场文件对交流参与这一概念进行了定义和描述。文中回顾了这一概念的出现，以及构音障碍中交流参与的预测因素和相关变量。在此过程中，通过强调交流参与不能仅从世界卫生组织《国际功能、残疾和健康分类》（ICF）的其他组成部分（包括损伤水平或活动受限）来预测，突出了使交流参与有别于其他构音障碍测量方法的独特特征。接下来，介绍了与交流参与测量相关的实证文献，以及该研究与构音障碍管理的关系。最后，从临床医生的角度描述了交流参与的可靠临床测量方法的发展和管理方法。我们认为，交流参与应成为治疗计划和干预的主要重点，以提供以患者为中心、全面且基于价值的临床干预措施，满足构音障碍患者的需求。
